# Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-adjunctive-ezogabine-retigabine-in-refractory-partial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Martin J. Brodie,Holger Lerche,António Gil‐Nagel,Christian E. Elger,Susan T. Hall,Paul Shin,Virinder Nohria,Harry H. Mansbach,On behalf of the RESTORE 2 Study Group |
| Citations | 192 |
| DOI | 10.1212/wnl.0b013e3181fd6170 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2033494215 |
| PMID | 20944074 |
| Type | article |
| Year | 2010 |

## Paper authors

- [António Gil‐Nagel](https://scholariq.org/researchers/antonio-gil-nagel/)

## Paper journal

- [Neurology](https://scholariq.org/journals/neurology/)

## Paper primary topic

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)

## Paper topics

- [Epilepsy research and treatment](https://scholariq.org/topics/epilepsy-research-and-treatment/)
- [Ion channel regulation and function](https://scholariq.org/topics/ion-channel-regulation-and-function/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.